氰基丙烯酸酯胶固定补片用于腹腔镜腹股沟疝修补术:一项前瞻性、多中心、单臂研究
这项前瞻性、多中心、单臂研究评估了正己基氰基丙烯酸酯胶Ifabond™在腹腔镜腹股沟疝修补术中固定补片的效果。共613例患者接受手术,术后5周和12个月疼痛评分较术前显著下降,生活质量改善,12个月随访时慢性疼痛发生率为13.74%,复发2例。作者认为Ifabond™是一种安全、可靠、可行的固定方法。
要点
- 术后疼痛评分从术前26.96±19.42降至5周3.97±10.04和12个月3.83±11.26(p<0.0001)。
- 12个月随访时慢性腹股沟疼痛发生率为13.74%,其中2.67%需镇痛药。
- EQ-5D-3L指数从术前0.82±0.19升至12个月0.92±0.15(p<0.0001)。
核心结论
- Ifabond™是腹腔镜腹股沟疝修补术中安全、可靠、可行的补片固定方法,外科医生满意度高,患者生活质量改善,慢性疼痛和术后并发症风险与文献报道相当。
研究设计与样本
- 前瞻性、多中心、单臂研究,纳入613例接受腹腔镜腹股沟疝修补术并使用Ifabond™固定补片的患者,补片为标准或轻量聚丙烯补片,术后5周和12个月随访。
主要发现
- 术后疼痛评分从术前26.96±19.42降至5周3.97±10.04(p<0.0001)和12个月3.83±11.26(p<0.0001)。
- 12个月随访时115例(13.74%)出现慢性腹股沟疼痛,其中14例(2.67%)需使用镇痛药。
- 6例发生严重并发症,1例死于无关原因,12个月随访期间发生2例疝复发。
- EQ-5D-3L指数从术前0.82±0.19升至5周0.90±0.15(p<0.0001)和12个月0.92±0.15(p<0.0001)。
- EQ-VAS总体健康评分从术前79.03±12.69升至5周84.31±9.97(p<0.0001)和12个月84.16±14.48(p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inguinal hernia repair is among the most frequently performed surgical procedures. Alternatives to penetrating mesh fixation, such as surgical glue, are being investigated for their potential benefit in reducing chronic pain. The aim of this study was to assess the efficacy of the n-hexyl cyanoacrylate glue Ifabond™ for mesh fixation in laparoscopic inguinal hernia repair. METHODS: This prospective, multicenter, single-arm study collected data from laparoscopic inguinal hernia repairs using Ifabond™ (Peters Surgical, Boulogne-Billancourt Cedex, France) and a standard [Promesh® SURG ST (Peters Surgical)/Biomesh® P1 (Cousin Biotech, Wervicq-Sud, France)] or lightweight [Promesh® SURG LI (Peters Surgical)/Premium® Implant (Cousin Biotech)] polypropylene mesh. The primary endpoint was postoperative pain [100-scale Visual Analog Scale (VAS)]. Secondary endpoints were complications, hernia recurrences, and quality of life (QoL) (EQ-5D-3L health index and EQ-VAS). Patients were followed up at 5 weeks and 12 months after surgery. RESULTS: Six-hundred and thirteen patients underwent laparoscopic inguinal hernia repair. Postoperative pain decreased at 5-week (3.97 ± 10.04; p < 0.0001) and 12-month (3.83 ± 11.26; p < 0.0001) follow-up compared with before surgery (26.96 ± 19.42). One hundred and fifteen patients (13.74%) experienced chronic pain in the groin at 12-month follow-up, of whom 14 (2.67%) required analgesics. There were 6 patients with major morbidities and one patient died of an unrelated cause. Two hernia recurrences occurred within 12-month follow-up. Patients' QoL increased from an EQ-5D-3L index score of 0.82 ± 0.19 preoperatively to 0.90 ± 0.15 at 5 weeks (p < 0.0001) and 0.92 ± 0.15 at 12 months after surgery (p < 0.0001). The EQ-VAS general health scoring increased from 79.03 ± 12.69 preoperatively to 84.31 ± 9.97 at 5-week (p < 0.0001) and 84.16 ± 14.48 at 12-month follow-up (p < 0.0001). CONCLUSIONS: Ifabond™ (Peters Surgical) is a safe, reliable, and feasible fixation method for laparoscopic inguinal hernia repair with a very high surgeon satisfaction score, improved patients' QoL, and comparable risk of developing chronic pain and postoperative complications as described in the literature.
引用
- Dams A, Vankeirsbilck J, Poelmans S, et al. Cyanoacrylate mesh fixation for laparoscopic inguinal hernia repair: a prospective, multicenter, single-arm study. Surg Endosc. 2023. PMID: 37798529. doi:10.1007/s00464-023-10439-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。